Press "Enter" to skip to content

Government as the First Investor in Biopharmaceutical Innovation

1
Listen to this article
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/
United States Capitol Building in Washington DC

Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government funding in recently approved drugs.

They focused on the 356 new drugs approved by the U.S. Food and Drug Administration from 2010-2019 and found:

  • Research on the 356 drugs comprised 244,000 publications, of which 39,000 were supported by NIH funding
  • NIH funding also produced 22,000 patents, which provided marketing exclusivity for 27 (8.6%) of the drugs

For more details, see the full paper at https://www.ineteconomics.org/uploads/papers/WP_133-Cleary-et-al-Govt-innovation.pdf

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions